---
reference_id: "PMID:32861158"
title: Spikes/spike-waves time-locked to the flash frequency during intermittent light stimulation in Jeavons syndrome.
authors:
- Nilo A
- Crespel A
- Genton P
- Macorig G
- Gigli GL
- Gelisse P
journal: Clin Neurophysiol
year: '2020'
doi: 10.1016/j.clinph.2020.07.012
content_type: abstract_only
---

# Spikes/spike-waves time-locked to the flash frequency during intermittent light stimulation in Jeavons syndrome.
**Authors:** Nilo A, Crespel A, Genton P, Macorig G, Gigli GL, Gelisse P
**Journal:** Clin Neurophysiol (2020)
**DOI:** [10.1016/j.clinph.2020.07.012](https://doi.org/10.1016/j.clinph.2020.07.012)

## Content

1. Clin Neurophysiol. 2020 Oct;131(10):2479-2481. doi: 
10.1016/j.clinph.2020.07.012. Epub 2020 Aug 6.

Spikes/spike-waves time-locked to the flash frequency during intermittent light 
stimulation in Jeavons syndrome.

Nilo A(1), Crespel A(2), Genton P(3), Macorig G(4), Gigli GL(5), Gelisse P(2).

Author information:
(1)Epilepsy Unit, Hôpital Gui de Chauliac, Montpellier, France; Clinical 
Neurology Unit, Department of Neurosciences, S. Maria della Misericordia 
University Hospital, Udine, Italy. Electronic address: 
annacarmen.nilo@gmail.com.
(2)Epilepsy Unit, Hôpital Gui de Chauliac, Montpellier, France; Research Unit 
(URCMA: Unité de Recherche sur les Comportements et Mouvements Anormaux), 
INSERM, U661, Montpellier F-34000, France.
(3)Centre Saint Paul-H. Gastaut, Marseille, France.
(4)Epilepsy Unit, Hôpital Gui de Chauliac, Montpellier, France; Neurology Unit, 
San Giovanni di Dio Hospital, Gorizia, Italy.
(5)Clinical Neurology Unit, Department of Neurosciences, S. Maria della 
Misericordia University Hospital, Udine, Italy; DMIF, University of Udine, 
Udine, Italy.

DOI: 10.1016/j.clinph.2020.07.012
PMID: 32861158 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of Competing Interest Dr. Nilo, Pr. 
Gigli and Dr. Macorig report no conflicts of interest. Dr. Crespel received 
support for teaching programs from Sanofi, UCB, GSK, Shire and is an advisory 
board member for Eisai-France. Dr. Genton received speaker invitations and 
honoraria from Sanofi-Aventis, Novartis, GSK, Pfizer, Janssen-Cilag, UCB, Eisai, 
and Actelion. He received support for teaching programs from Sanofi-Aventis and 
UCB. Dr. Gelisse received support for teaching programs from Sanofi, UCB, EISAI 
and Psicofarma. He received a research grant from Janssen-Cilag. He worked as a 
consultant for Eisai-France in 2011.